Bloomberg's Shannon Pettypiece reports on investor interest in AstraZeneca Plc after nomination of a new chairman stoked speculation that Chief Executive Officer David Brennan’s days in the job may be drawing to an end. The company may also consider a merger with Bristol-Myers Squibb Co. She speaks on Bloomberg Television's "In The Loop." (Source: Bloomberg)

Running Time: 02:20